Återgå till huvudnavigering Återgå till sök Gå direkt till huvudinnehållet

Identification of Unique Peptides for SARS-CoV-2 Diagnostics and Vaccine Development by an In Silico Proteomics Approach

  • Veerbhan Kesarwani
  • , Rupal Gupta
  • , Ramesh Vetukuri
  • , Sandeep Kumar Kushwaha
  • , Sonu Gandhi

Publikation: Bidrag till tidskrift › Artikel i vetenskaplig tidskrift › Peer review

4 Nedladdningar

Sammanfattning

Ongoing evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus strains is posing new COVID-19 diagnosis and treatment challenges. To help efforts to meet these challenges we examined data acquired from proteomic analyses of human SARS-CoV-2-infected cell lines and samples from COVID-19 patients. Initially, 129 unique peptides were identified, which were rigorously evaluated for repeats, disorders, polymorphisms, antigenicity, immunogenicity, toxicity, allergens, sequence similarity to human proteins, and contributions from other potential cross-reacting pathogenic species or the human saliva microbiome. We also screened SARS-CoV-2-infected NBHE and A549 cell lines for presence of antigenic peptides, and identified paratope peptides from crystal structures of SARS-CoV-2 antigen-antibody complexes. We then selected four antigen peptides for docking with known viral unbound T-cell receptor (TCR), class I and II peptide major histocompatibility complex (pMHC), and identified paratope sequences. We also tested the paratope binding affinity of SARS-CoV T- and B-cell peptides that had been previously experimentally validated. The resultant antigenic peptides have high potential for generating SARS-CoV-2-specific antibodies, and the paratope peptides can be directly used to develop a COVID-19 diagnostics assay. The presented genomics and proteomics-based in-silico approaches have apparent utility for identifying new diagnostic peptides that could be used to fight SARS-CoV-2.
OriginalspråkEngelska
Artikelnummer725240
Antal sidor14
TidskriftFrontiers in Immunology
Volym12
DOI
StatusPublicerad - 2021

FN:s SDG:er

Detta resultat bidrar till följande hållbara utvecklingsmål:

  1. SDG 3 – God hälsa och välbefinnande
    SDG 3 – God hälsa och välbefinnande

Nyckelord

  • SARS-CoV-2
  • COVID-19 vaccines
  • diagnostic peptides
  • docking
  • paratopes
  • TCR
  • MHC

Citera det här